RXI PHARMACEUTICALS CORP NEW's ticker is RXIIW and the CUSIP is 74979C113. A total of 4 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $273,000 | -23.1% | 2,100,797 | 0.0% | 0.02% | +8.7% |
| Q3 2017 | $355,000 | -11.2% | 2,100,797 | -5.4% | 0.02% | -11.5% |
| Q2 2017 | $400,000 | -18.7% | 2,220,492 | -0.8% | 0.03% | -3.7% |
| Q1 2017 | $492,000 | +8.4% | 2,238,487 | -1.4% | 0.03% | +3.8% |
| Q4 2016 | $454,000 | – | 2,270,283 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 2,221,722 | $1,235,000 | 0.83% |
| SABBY MANAGEMENT, LLC | 2,100,797 | $273,000 | 0.02% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 30,000 | $4,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,216,855 | $288,000 | 0.00% |